Advertisement
Screener

ADMA BIOLOGICS, INC. (ADMA) Amortization of Intangible Assets

2.8 / 5 stars · 68/120 Roast Me

ADMA BIOLOGICS, INC. Amortization of Intangible Assets

ADMA BIOLOGICS, INC. (ADMA) reported Amortization of Intangible Assets of $55.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-05

  • ADMA BIOLOGICS, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $55.00K, a 71.88% increase year-over-year.
  • ADMA BIOLOGICS, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $55.00K, a 120.00% increase year-over-year.
  • ADMA BIOLOGICS, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $51.00K, a 104.00% increase year-over-year.
  • ADMA BIOLOGICS, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $38.00K, a 35.71% increase year-over-year.
  • ADMA BIOLOGICS, INC. amortization of intangible assets for fiscal 2025 was $144.00K, a 62.89% decline from fiscal 2024.
  • ADMA BIOLOGICS, INC. amortization of intangible assets for fiscal 2024 was $388.00K, a 46.41% decline from fiscal 2023.
  • ADMA BIOLOGICS, INC. amortization of intangible assets for fiscal 2023 was $724.00K, a 1.26% increase from fiscal 2022.
  • ADMA BIOLOGICS, INC. amortization of intangible assets for fiscal 2022 was $715.00K, a 0.00% change from fiscal 2021.
Period endAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 3 month as first filedAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 6 month as first filedAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 9 month as first filedAmortization of Intangible Assets 12 monthAmortization of Intangible Assets 12 month as first filed
2026-06-30$55.00K
10-Q · filed 2026-08-05
$110.00K
10-Q · filed 2026-08-05
$161.00K
derived: sum of 3 quarters · filed 2026-08-05
$199.00K
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$55.00K
10-Q · filed 2026-05-06
$106.00K
derived: sum of 2 quarters · filed 2026-05-06
$144.00K
derived: sum of 3 quarters · filed 2026-05-06
$176.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$51.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$89.00K
derived: sum of 2 quarters · filed 2026-02-25
$121.00K
derived: sum of 3 quarters · filed 2026-08-05
$144.00K
10-K · filed 2026-02-25
2025-09-30$38.00K
10-Q · filed 2025-11-05
$70.00K
derived: sum of 2 quarters · filed 2026-08-05
$93.00K
10-Q · filed 2025-11-05
$120.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$32.00K
10-Q · filed 2026-08-05
$57.00K
10-Q · filed 2026-08-05
$82.00K
derived: sum of 3 quarters · filed 2026-08-05
$110.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$25.00K
10-Q · filed 2026-05-06
$50.00K
derived: sum of 2 quarters · filed 2026-05-06
$78.00K
derived: sum of 3 quarters · filed 2026-05-06
$220.00K
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$25.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$53.00K
derived: sum of 2 quarters · filed 2026-02-25
$195.00K
derived: sum of 3 quarters · filed 2026-02-25
$388.00K
10-K · filed 2026-02-25
2024-09-30$28.00K
10-Q · filed 2025-11-05
$170.00K
derived: sum of 2 quarters · filed 2025-11-05
$363.00K
10-Q · filed 2025-11-05
$550.00K
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30$142.00K
10-Q · filed 2025-08-06
$335.00K
10-Q · filed 2025-08-06
$522.00K
derived: sum of 3 quarters · filed 2026-02-25
$701.00K
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31$193.00K
10-Q · filed 2025-05-07
$380.00K
derived: sum of 2 quarters · filed 2026-02-25
$559.00K
derived: sum of 3 quarters · filed 2026-02-25
$738.00K
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31$187.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$366.00K
derived: sum of 2 quarters · filed 2026-02-25
$545.00K
derived: sum of 3 quarters · filed 2026-02-25
$724.00K
10-K · filed 2026-02-25
2023-09-30$179.00K
10-Q · filed 2024-11-07
$178.84K
10-Q · filed 2023-11-08
$358.00K
derived: sum of 2 quarters · filed 2024-11-07
$537.00K
10-Q · filed 2024-11-07
$536.51K
10-Q · filed 2023-11-08
$715.49K
derived: sum of 4 quarters · filed 2025-03-18
2023-06-30$179.00K
10-Q · filed 2024-08-08
$178.84K
10-Q · filed 2023-08-09
$358.00K
10-Q · filed 2024-08-08
$357.68K
10-Q · filed 2023-08-09
$536.49K
derived: sum of 3 quarters · filed 2025-03-18
$715.32K
derived: sum of 4 quarters · filed 2025-03-18
2023-03-31$179.00K
10-Q · filed 2024-05-09
$178.84K
10-Q · filed 2023-05-10
$357.49K
derived: sum of 2 quarters · filed 2025-03-18
$536.32K
derived: sum of 3 quarters · filed 2025-03-18
$715.16K
derived: sum of 4 quarters · filed 2025-03-18
2022-12-31$178.49K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
$357.32K
derived: sum of 2 quarters · filed 2025-03-18
$536.16K
derived: sum of 3 quarters · filed 2025-03-18
$715.00K
10-K · filed 2025-03-18
$715.35K
10-K · filed 2023-03-23
2022-09-30$178.84K
10-Q · filed 2023-11-08
$357.68K
derived: sum of 2 quarters · filed 2023-11-08
$536.51K
10-Q · filed 2023-11-08
$715.00K
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$178.84K
10-Q · filed 2023-08-09
$357.68K
10-Q · filed 2023-08-09
$536.16K
derived: sum of 3 quarters · filed 2024-02-28
$715.00K
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$178.84K
10-Q · filed 2023-05-10
$357.32K
derived: sum of 2 quarters · filed 2024-02-28
$536.16K
derived: sum of 3 quarters · filed 2024-02-28
$715.00K
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$178.49K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$357.32K
derived: sum of 2 quarters · filed 2024-02-28
$536.16K
derived: sum of 3 quarters · filed 2024-02-28
$715.00K
10-K · filed 2024-02-28
$715.35K
10-K · filed 2022-03-24
2021-09-30$178.84K
10-Q · filed 2022-11-09
$357.68K
derived: sum of 2 quarters · filed 2022-11-09
$536.51K
10-Q · filed 2022-11-09
$715.35K
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$178.84K
10-Q · filed 2022-08-10
$357.68K
10-Q · filed 2022-08-10
$536.51K
derived: sum of 3 quarters · filed 2022-08-10
$715.35K
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31$178.84K
10-Q · filed 2022-05-11
$357.68K
derived: sum of 2 quarters · filed 2022-05-11
$536.51K
derived: sum of 3 quarters · filed 2022-05-11
$715.35K
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31$178.84K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24
$357.68K
derived: sum of 2 quarters · filed 2022-03-24
$536.51K
derived: sum of 3 quarters · filed 2022-03-24
$715.35K
10-K · filed 2022-03-24
2020-09-30$178.84K
10-Q · filed 2021-11-10
$357.68K
derived: sum of 2 quarters · filed 2021-11-10
$536.51K
10-Q · filed 2021-11-10
$747.75K
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$178.84K
10-Q · filed 2021-08-11
$357.68K
10-Q · filed 2021-08-11
$568.91K
derived: sum of 3 quarters · filed 2021-08-11
$780.14K
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$178.84K
10-Q · filed 2021-05-12
$390.07K
derived: sum of 2 quarters · filed 2021-05-12
$601.31K
derived: sum of 3 quarters · filed 2021-05-12
$812.54K
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$211.23K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
$422.47K
derived: sum of 2 quarters · filed 2021-03-25
$633.70K
derived: sum of 3 quarters · filed 2021-03-25
$844.94K
10-K · filed 2021-03-25
2019-09-30$211.24K
10-Q · filed 2020-11-05
$422.47K
derived: sum of 2 quarters · filed 2020-11-05
$633.70K
10-Q · filed 2020-11-05
$844.94K
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$211.23K
10-Q · filed 2020-08-05
$422.47K
10-Q · filed 2020-08-05
$633.70K
derived: sum of 3 quarters · filed 2020-08-05
$844.94K
derived: sum of 4 quarters · filed 2020-08-05
2019-03-31$211.24K
10-Q · filed 2020-05-06
$422.47K
derived: sum of 2 quarters · filed 2020-05-06
$633.70K
derived: sum of 3 quarters · filed 2020-05-06
$844.94K
derived: sum of 4 quarters · filed 2020-05-06
2018-12-31$211.23K
10-K · filed 2019-03-13
$422.47K
derived: sum of 2 quarters · filed 2019-11-06
$633.70K
derived: sum of 3 quarters · filed 2019-11-06
$844.94K
10-K · filed 2020-03-13
2018-09-30$211.24K
10-Q · filed 2019-11-06
$422.47K
derived: sum of 2 quarters · filed 2019-11-06
$633.70K
10-Q · filed 2019-11-06
$1.52M
derived: sum of 4 quarters · filed 2019-11-06
2018-06-30$211.23K
10-Q · filed 2019-08-08
$422.47K
10-Q · filed 2019-08-08
$1.31M
derived: sum of 3 quarters · filed 2019-08-08
$1.58M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$211.24K
10-Q · filed 2019-05-08
$1.10M
derived: sum of 2 quarters · filed 2019-05-08
$1.37M
derived: sum of 3 quarters · filed 2019-05-08
$1.45M
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31$887.83K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
$1.16M
derived: sum of 2 quarters · filed 2019-03-13
$1.23M
derived: sum of 3 quarters · filed 2019-03-13
$1.23M
10-K · filed 2019-03-13
2017-09-30$273.83K
10-Q · filed 2018-11-09
$346.85K
derived: sum of 2 quarters · filed 2018-11-09
$346.85K
10-Q · filed 2018-11-09
$346.85K
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30$73.02K
10-Q · filed 2018-08-10
$73.02K
10-Q · filed 2018-08-10
$73.02K
derived: sum of 3 quarters · filed 2018-08-10
$73.02K
derived: sum of 4 quarters · filed 2018-08-10
2017-03-31$0.00
10-Q · filed 2018-05-14
$0.00
derived: sum of 2 quarters · filed 2018-05-14
$0.00
derived: sum of 3 quarters · filed 2018-05-14
$0.00
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29
$0.00
derived: sum of 2 quarters · filed 2018-03-29
$0.00
derived: sum of 3 quarters · filed 2018-03-29
$0.00
10-K · filed 2018-03-29
2016-09-30$0.00
10-Q · filed 2017-11-03
$0.00
derived: sum of 2 quarters · filed 2017-11-03
$0.00
10-Q · filed 2017-11-03
2016-06-30$0.00
10-Q · filed 2017-08-11
$0.00
10-Q · filed 2017-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43